An international prospective umbrella trial for children with atypical teratoid/rhabdoid tumours (ATRT) including a randomized phase III study evaluating the non-inferiority of three courses of high-dose chemotherapy (HDCT) compared to focal radiotherapy as consolidation therapy

Beteiligte Wissenschaftler:
Akad. Rat Dr. Dipl.-Stat. J. Gerß

Studienleitung:
Prof. Dr. Dr. med. M. C. Frühwald

Förderung:
Deutsche Kinderkrebsstiftung

Förderzeitraum:
2021-2029